Hind Mellah
20 august 1953 Hospital, Casablanca
About the Ocular Melanoma Session
Ocular melanoma, a rare yet formidable cancer, originates in the melanocytes of the eye, specifically within the uvea—a crucial layer encompassing the iris, ciliary body, and choroid. These melanocytes, responsible for pigment production, undergo malignant transformation, leading to potential symptoms like vision blurring, light flashes, or dark spots on the iris.
Diagnosis typically involves a thorough eye examination supplemented by imaging techniques such as ultrasound or MRI scans. Treatment strategies vary based on tumor size and location, ranging from surgical interventions and radiation therapy to, in severe cases, enucleation (eye removal). Early detection through regular eye check-ups remains pivotal for optimizing treatment efficacy and patient outcomes in managing this challenging condition.
Topics Covered in Ocular Melanoma
Topic 01
Choroidal Melanoma
Topic 02
Iris Melanoma
Topic 03
Ciliary Body Melanoma
Topic 04
Conjunctival Melanoma
Topic 05
Ocular Ultrasonography
Topic 06
Metastatic Risk Profiling
Featured Speakers — Ocular Melanoma 2027
Toluwalogo Daramola
North Cumbria Integrated Care NHS Foundation Trust
Recent Research Presented at Ocular Melanoma Sessions
Ciliary body melanoma revealed by painful ocular hypertension: An unusual clinical presentation (a case report)
Background : Ciliary body melanoma is a rare intraocular malignancy, accounting for less than 5% of uveal melanomas. Due to its retro iridal location and late functional manifestations, diagnosis may…
More than a cataract: Choroidal melanoma diagnosed on B-scan ultrasonography following an abnormal pre-operative examination
Background: Choroidal melanoma is the most common primary intraocular malignancy in adults, arising from melanocytes within the uveal tract. It makes up to 90% uveal melanomas, followed by tumours of…
Diagnostic uncertainty with a patient presenting with raised intra-ocular pressure. A unique case of choroidal melanoma
Introduction: This case report discusses a patient presenting with elevated Intraocular Pressure (IOP) unresponsive to oral or intravenous treatment, necessitating urgent cyclodiode intervention.…
Rare and interesting case of choroidal melanoma presenting as a case of a congestive glaucoma left eye in a 55 years old male patient
Choroidal melanomas are one of the commonest intraocular tumours which are kind of being malignant. Pigmented non pigmented more common in whites than blacks has got an early Tendency for liver…
Related Scientific Sessions at IOC 2027
Why Attend the Ocular Melanoma Conference 2027
Earn CPD Credit
Sessions are CPD-accredited by The CPD Group (UK) — one CPD credit for every hour of attendance.
Present Your Research
Oral and poster slots for original Ocular Melanoma work, reviewed by the scientific committee.
Network Globally
Meet ophthalmologists, vision scientists, and eye-care clinicians from around the world across three days.
Publish & Get Indexed
Accepted abstracts are compiled into the conference proceedings and indexed in Scopus and Web of Science.
Learn from Keynotes
Plenary lectures from leading voices shaping Ocular Melanoma research and practice.
Hybrid Flexibility
Attend in person in Singapore or join virtually — same programme, same certificate.
Join IOC 2027 for the Ocular Melanoma track
Oral and poster slots for your work — in person in Singapore or online. Not presenting? Attend as a delegate to learn from the field.
Ocular Melanoma Conference 2027 — FAQs
What is the Ocular Melanoma track at IOC 2027?
The Ocular Melanoma track is a dedicated stream within IOC 2027 covering the latest research, clinical innovation, and best practice in Ocular Melanoma. It brings together researchers, educators, and practitioners for oral presentations, posters, and discussion.
Who should attend the Ocular Melanoma sessions?
Ophthalmologists, optometrists, vision scientists, educators, doctoral students, and trainees with an interest in Ocular Melanoma are all welcome — whether presenting or attending.
Can I present my research in the Ocular Melanoma track?
Yes. Submit an abstract for oral or poster presentation. All submissions are peer-reviewed by the scientific committee; accepted abstracts appear in the indexed proceedings.
Is virtual attendance available for Ocular Melanoma sessions?
Yes. IOC 2027 is a hybrid conference — attend the Ocular Melanoma track in person in Singapore or join live online, with on-demand access afterward.
Join the IOC 2027 delegation
Singapore · March 15–17, 2027· Hybrid · in-person & virtual
Register as Delegate →
Attend without presenting.